DE1617545C2 - Verwendung von informatorischer Ribonucleinsäure als Vaccine - Google Patents

Verwendung von informatorischer Ribonucleinsäure als Vaccine

Info

Publication number
DE1617545C2
DE1617545C2 DE1617545A DE1617545A DE1617545C2 DE 1617545 C2 DE1617545 C2 DE 1617545C2 DE 1617545 A DE1617545 A DE 1617545A DE 1617545 A DE1617545 A DE 1617545A DE 1617545 C2 DE1617545 C2 DE 1617545C2
Authority
DE
Germany
Prior art keywords
informational
vaccine
cell
antigen
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1617545A
Other languages
German (de)
English (en)
Other versions
DE1617545A1 (de
Inventor
Diether Prof. Dr. Bern Jachertz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE1617545A1 publication Critical patent/DE1617545A1/de
Application granted granted Critical
Publication of DE1617545C2 publication Critical patent/DE1617545C2/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE1617545A 1967-06-19 1967-06-19 Verwendung von informatorischer Ribonucleinsäure als Vaccine Expired DE1617545C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEJ0033936 1967-06-19

Publications (2)

Publication Number Publication Date
DE1617545A1 DE1617545A1 (de) 1971-04-01
DE1617545C2 true DE1617545C2 (de) 1983-11-03

Family

ID=7204943

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1617545A Expired DE1617545C2 (de) 1967-06-19 1967-06-19 Verwendung von informatorischer Ribonucleinsäure als Vaccine

Country Status (13)

Country Link
AT (1) AT282821B (nl)
BE (1) BE716806A (nl)
BR (1) BR6899970D0 (nl)
CH (1) CH513241A (nl)
DE (1) DE1617545C2 (nl)
DK (1) DK119724B (nl)
ES (1) ES355121A1 (nl)
FR (2) FR1588820A (nl)
GB (1) GB1229888A (nl)
IE (1) IE32140B1 (nl)
IL (1) IL30168A (nl)
NL (1) NL6808486A (nl)
NO (1) NO124840B (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3115559A1 (de) * 1981-04-16 1982-10-28 Kommanditgesellschaft Schwarzhaupt, 5000 Köln Hochgereinigte informatorische ribonukleinsaeure (i-rns), verfahren zur herstellung und verwendung derselben

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754934A (fr) * 1969-08-16 1971-02-17 Jachertz Diether Procede de production enzymatique d'arn-messager
GB1594097A (en) 1976-12-16 1981-07-30 Int Inst Of Differentiation Production of specific immune nucleic acids cell dialysates and antibodies
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
US6214804B1 (en) 1989-03-21 2001-04-10 Vical Incorporated Induction of a protective immune response in a mammal by injecting a DNA sequence
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6673776B1 (en) 1989-03-21 2004-01-06 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
US6867195B1 (en) 1989-03-21 2005-03-15 Vical Incorporated Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3115559A1 (de) * 1981-04-16 1982-10-28 Kommanditgesellschaft Schwarzhaupt, 5000 Köln Hochgereinigte informatorische ribonukleinsaeure (i-rns), verfahren zur herstellung und verwendung derselben

Also Published As

Publication number Publication date
BE716806A (nl) 1968-12-19
FR7781M (nl) 1970-03-23
DK119724B (da) 1971-02-15
NO124840B (nl) 1972-06-12
BR6899970D0 (pt) 1973-02-13
AT282821B (de) 1970-07-10
CH513241A (de) 1971-09-30
FR1588820A (nl) 1970-03-16
NL6808486A (nl) 1968-12-20
IE32140L (en) 1968-12-19
ES355121A1 (es) 1969-11-16
IE32140B1 (en) 1973-04-18
GB1229888A (nl) 1971-04-28
IL30168A (en) 1973-05-31
DE1617545A1 (de) 1971-04-01
IL30168A0 (en) 1968-08-22

Similar Documents

Publication Publication Date Title
AT408615B (de) Neue influenzavirus-impfstoffzusammensetzung
DE3911442C2 (de) Impfstoff-Präparation
DE69732407T3 (de) Verfahren für die Replikation von Influenza in Zellkultur und die bei diesem Verfahren hergestellten Influenza-Viren
DE69334066T2 (de) Impfstoffzusammensetzungen für mukosale Abgabe
WO1989007946A1 (en) Virally modified tumour vaccines for immunotherapy of tumour metastases
EP0304786A2 (de) Intranasale Impfung von Pferden mit inaktivierten Mikroorganismen oder antigenem Material
DE1617545C2 (de) Verwendung von informatorischer Ribonucleinsäure als Vaccine
DE2713371C2 (nl)
DE3882781T2 (de) Impfstoff gegen Pasteurella.
DE3636826A1 (de) Varicella-zoster-immunglobulin mit hohem titer fuer eine intravenoese verabreichung
DE2445819A1 (de) Verfahren zur herstellung stabiler, gegen seruminhibitoren resistenter h tief 3 n tief 2 -influenzavirusstaemme und diese virusstaemme enthaltende vakzinen
CH616959A5 (nl)
DE69420970T2 (de) Impfstoff zubereitungen
CH630807A5 (de) Verfahren zur herstellung eines antiserums.
DE3034238A1 (de) Impfstoff zur bekaempfung der newcastle-krankheit und verfahren zur herstellung derselben
DE69127975T2 (de) Impfstoffe
DE69116155T2 (de) Neuramidase und glulaktoseoxidase als vaccinadjuvans
EP1265631B1 (de) Verfahren zur herstellung von vakzinen die eine hitzebehandelte mischung von zumindest einem antigen mit zumindest einem adjuvans enthält
DE2805311A1 (de) Respiratorische synzytial-vakzine
DE1966436C3 (de) Verwendung einer Antigen-Immunserum-Kombination als Impfstoff
DE2340911A1 (de) Tetanus-antigen und verfahren zu seiner herstellung
DE3877102T2 (de) Methode fuer die behandlung von viraler gehirnentzuendung.
DE1902590C2 (de) Verwendung einer Immunribonucleinsäure (IRNS) zum Immunisieren lebender Tiere
DE2157148A1 (de) Immunisierungsmittel, verfahren zur herstellung und seine verwendung
DE1617288C (de) Verfahren zur Herstellung eines Grippe virusimpfstoffs

Legal Events

Date Code Title Description
8125 Change of the main classification

Ipc: A61K 31/675

8181 Inventor (new situation)

Free format text: ERFINDER IST ANMELDER

D2 Grant after examination
8364 No opposition during term of opposition